Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (23) , 5787-5791
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase InhibitorsJournal of Medicinal Chemistry, 2002
- The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-positionBioorganic & Medicinal Chemistry Letters, 2001
- Synthesis and Azannulation of Pyridinylaminohexadienones.Chemical and Pharmaceutical Bulletin, 2001
- Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomasCancer Letters, 2000
- Synthesis and antitumour activity of 4-hydroxy-2-pyridone derivativesEuropean Journal of Medicinal Chemistry, 2000
- Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivoNature Medicine, 1999
- Annulation of functionalized hexadienones as an efficient regioselective approach to N-aryl-2-trifluoromethyl)-4-pyridinaminesTetrahedron Letters, 1999
- Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivativesBioorganic & Medicinal Chemistry Letters, 1999
- Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivoBritish Journal of Pharmacology, 1997
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI: Journal of the National Cancer Institute, 1991